Monograph
N07BB03 - Acamprosate |
Propably not porphyrinogenic |
PNP |
Rationale
Structurally related to taurine and GABA. Not metabolised, excreted in unchanged form in urine. One reference consider it safe.
Chemical description
Aliphatic aminopropane sulfonate. Used to reduce risk for relapse in alcohol dependence. Structurally related taurine and GABA. Its acetylation permits passage through the blood-brain barrier. Excreted in unchanged form by the kidneys. French list: use
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Campral · Campral 333 mg, maagsapresistente tabletten · Campral, maagsapresistente tabletten 333 mgBelgium
Campral · Campral 333 mg compr. gastro-résist.United Kingdom
Acamprosate · Acamprosate 333mg gastro-resistant tablets · Campral EC · Campral EC 333mg tabletsDenmark
Acamprosatcalcium · Acamprosatcalcium "2care4" · CampralNorway
CampralPoland
CampralLuxembourg
CAMPRALSerbia
Campral · Campral®
© NAPOS 2024